Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences

Clinical Microbiology and Infection

Volumn 14, Issue 7, 2008, Pages 677-684

  Bosis, S ^a   Esposito, S ^a   Niesters, H G M ^b   Zuccotti, G V ^c   Marseglia, G ^d   Lanari, M ^e   Zuin, G ^f   Pelucchi, C ^g   Osterhaus, A D M E ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e Hospital of Imola   (Italy)

^f V BUZZI CHILDREN S HOSPITAL   (Italy)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Asthma; Atypical bacteria; Respiratory syncytial virus; Respiratory viruses; Wheezing

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; INFUSION FLUID; OXYGEN;

ACUTE DISEASE; ADENOVIRUS; ARTICLE; BACTERIAL INFECTION; BOCAVIRUS; BREATHING EXERCISE; CHILD CARE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONAVIRUS; DISEASE SEVERITY; ENTEROVIRUS; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; INFANT; INFLUENZA VIRUS A; INFLUENZA VIRUS B; ITALY; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; NASOPHARYNGEAL ASPIRATION; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS 4; PARECHOVIRUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; THROAT CULTURE; VIRUS LOAD; VIRUS PATHOGENESIS; WHEEZING;

ADENOVIRIDAE; BOCAVIRUS; CORONAVIRUS; ENTEROVIRUS; HUMAN METAPNEUMOVIRUS; ORTHOMYXOVIRIDAE; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS; RICE STRIPE VIRUS;

EID: 45249124058     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02016.x     Document Type: Article

References (55)

1. Smyth RL, Openshaw PJM. Bronchiolitis. Lancet 2006; 368: 312-321.
2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774-1793.
3. Ramsey CD, Gold DR, Litonjua AA, Sredl DL, Ryan L, Celedón JC. Respiratory illnesses in early life and asthma and atopy in childhood. J Allergy Clin Immunol 2007; 119: 150-156.
4. Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: A review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med 2007; 175: 108-119.
5. Stein RT, Sherill D, Morgan WJ et.al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-545.
6. Simoes EA, Groothuis JR, Carbonell-Estrany X et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007; 151: 34-42.
7. Esposito S, Blasi F, Arosio C et al. Mycoplasma pneumoniae and Chlamydia pneumoniae infection in children with wheezing. Eur Respir J 2000; 16: 1142-1146.
8. Esposito S, Principi N. Asthma in children: Are Chlamydia or Mycoplasma involved? Paediatr Drugs 2001; 3: 159-168.
9. Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114: 239-247.
10. Papadopoulos NG, Kalobatsou A. Respiratory viruses in childhood asthma. Curr Opin Allergy Clin Immunol 2007; 7: 91-95.
11. Khetsuriani N, Kazzerouni NN, Erdman DD et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007; 119: 314-321.
12. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis 2001; 1: 334-344.
13. Esposito S, Droghetti R, Bosis S, Claut L, Marchisio P, Principi N. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol 2002; 34: 122-127.
14. Papadopoulos NG, Moustaki M, Tsolia M et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002; 165: 1285-1289.
15. Jartti T, Lehtinen P, Vuorinen T et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 2004; 10: 1095-1101.
16. Principi N, Esposito S, Bosis S. Human metapneumovirus in otherwise healthy infants and children. N Engl J Med 2004; 350: 1788-1790.
17. Esposito S, Bosis S, Faelli N et al. Role of atypical bacteria and azithromycin therapy in children with recurrent respiratory tract infections. Pediatr Infect Dis J 2005; 24: 438-444.
18. Esposito S, Gasparini R, Bosis S et al. Clinical and socioeconomic impact of influenza and respiratory syncytial virus (RSV) infection on healthy children and their households. Clin Microbiol Infect 2005; 11: 933-936.
19. Bosis S, Esposito S, Niesters HGM, Crovari P, Osterhaus ADME, Principi N. Impact of human metapneumovirus in childhood: Comparison with respiratory syncytial virus and influenza viruses. J Med Virol 2005; 75: 101-104.
20. Arnold JC, Singh KK, Spector SA, Sawyer MH. Human bocavirus: Prevalence and clinical spectrum at a children's hospital. Clin Infect Dis 2006; 43: 283-288.
21. Esposito S, Bosis S, Niesters HGM et al. Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. J Med Virol 2006; 78: 1609-1615.
22. Bosis S, Esposito S, Niesters HGM et al. Coronavirus HKU1 in an Italian pre-term infant with bronchiolitis. J Clin Virol 2007; 38: 251-253.
23. Allander T, Jartti T, Gupta S et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-910.
24. Melendi GA, Laham FR, Monsalvo AC et al. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics 2007; 120: E410-e415.
25. Dakhama A, Park JW, Taube C et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005; 175: 1876-1883.
26. You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006; 7: 107.
27. Mohtasham L, Auais A, Piedimonte G. Nerve growth factor mediates steroid-resistant inflammation in respiratory syncytial infection. Pediatr Pulmonol 2007; 42: 496-504.
28. Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases, 4th edn. Philadelphia, PY: W.B. Saunders Company, 1998.
29. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: An observational study. Lancet 2001; 358: 1410-1416.
30. Ward CL, Dempsey MH, Ring CJ et al. Design and performance testing of quantitative real time PCR assays for influenzaA and B viral load measurement. J Clin Virol 2004; 29: 179-188.
31. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70: 228-239. Erratum in: J Med Virol 2003; 71: 320.
32. Watzinger F, Suda M, Preuner S et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 2004; 42: 5189-5198.
33. Templeton KE, Forde CB, Loon AM et al. A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses. J Clin Virol 2006; 35: 51-58.
34. van den Hoogen BG, de Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-724.
35. van den Hoogen BG, van Doornum GJJ, Fockens JC et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003; 188: 1571-1577.
36. Maertzdorf J, Wang CK, Brown JB et al. Real-time reverse transcriptase PCR assay for detection of human metapneumovirus from all known genetic lineages. J Clin Microbiol 2004; 42: 981-986.
37. Fouchier RA, Hartwig NG, Bestebroer TM et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004; 101: 6212-6216.
38. Woo PCY, Lau SKP, Chu C, Tsoi HW, Chan KH, Yuen KY. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79: 884-895.
39. Monteny M, Niesters HG, Moll HA, Berger MY. Human bocavirus in febrile children, The Netherlands. Emerg Infect Dis 2007; 13: 180-182.
40. Jartti T, Waris M, Niesters HG, Allander T, Ruuskanen O. Respiratory viruses and acute asthma in children. J Allergy Clin Immunol 2007; 120: 216.
41. Van Doornum GJ, Schutten M, Voermans J, Guldemeester GJ, Niesters HG. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J Med Virol 2007; 79: 1868-1876.
42. Abele-Horn M, Busch U, Nitzschiko H et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol 1998; 36: 548-551.
43. Tompkins LS, Schachter J, Boman J et al. Collaborative multidisciplinary workshop report: Detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae. J Infect Dis 2000; 181 (suppl 3): S460-S461. Erratum in: J Infect Dis 2000; 182: 1581.
44. Peeling RW, Wang SP, Grayston JT et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis 2000; 181 (suppl 3): S426-S429.
45. Esposito S, Bosis S, Cavagna R et al. Characteristics of Streptococcus pneumoniae and atypical bacteria infections in children 2 to 5years of age with community-acquired pneumonia. Clin Infect Dis 2002; 35: 1345-1352.
46. Gasparini R, Durando P, Ansaldi F et al. Influenza and respiratory syncytial virus in infants and children: Relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains. Eur J Clin Microbiol Infect Dis 2007; 26: 619-628.
47. Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T-cell mediated disease during reinfection in adulthood. J Exp Med 2002; 196: 1381-1386.
48. Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Diaz PV. T.helper.1/ T.helper.2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 2006; 117: E878-e886.
49. Monick MM, Powers LS, Hassan I et al. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J Immunol 2007; 179: 1648-1658.
50. Lee FE, Walsh EE, Falsey AR et al. Human infant respiratory syncytial virus (RSV)-specific type.1 and 2 cytokine responses ex.vivo during primary RSV infection. J Infect Dis 2007; 195: 1779-1788.
51. DeVincenzo JP. Natural infection of infants with respiratory syncytial virus subgroups.A and B: A study of frequency, disease severity, and viral load. Pediatr Res 2004; 56: 914-917.
52. Somech R, Tal G, Gilad E, Mandelberg A, Tal A, Dalal I. Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants. Clin Pediatr 2006; 45: 621-627.
53. Lukacs NW, Moore ML, Rudd BD et al. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol 2006; 169: 977-986.
54. Buckingam SC, Bush AJ, DeVincenzo JP. Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J 2000; 19: 113-117.
55. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005; 191: 1861-1868.